MONROVIA –The national conversation on accountability, conflict of interest, and public trust has intensified following findings from a National Security Agency (NSA) investigation that placed Security Expert Guard Agency of Liberia (SEGAL) at the center of questions surrounding missing pharmaceutical commodities at the Central Medicine Store (CMS), while raising fresh concerns about the continued leadership role of Lofa County Senator Momo Tarnuekollie Cyrus on the Senate Committee on National Defense, Intelligence, Security, and Veteran Affairs.
By Selma Lomax, selma.lomax@frontpageafricaonline.com
The controversy has created a difficult political and ethical debate on whether Senator Cyrus, who co-founded SEGAL and previously served as the company’s General Manager, should continue leading a powerful Senate committee responsible for oversight of Liberia’s national security institutions while the private security firm remains under public scrutiny.
Senator Cyrus has rejected calls for him to step aside, arguing that he resigned from SEGAL’s management immediately after entering government and has no involvement in the company’s daily operations.
Through a statement issued by his office Tuesday, July 8, the senator maintained that SEGAL operates independently under its own management structure and that attempts to link him personally to ongoing investigations are based on assumptions rather than verified facts.
However, critics argue that the issue extends beyond direct management or ownership. They say the controversy raises questions about public confidence, ethical responsibility, and the standards expected of officials occupying influential government positions, especially when their former private institutions become connected to investigations involving national security and public resources.
NSA Findings Put SEGAL Under Spotlight
The debate surrounding Senator Cyrus comes after an NSA investigation into alleged missing medicines at the Central Medicine Store, which examined the roles of several individuals and institutions involved in the storage, management, security, and distribution of pharmaceutical commodities.
According to the findings, investigators reviewed statements from persons of interest, examined documents, and analyzed Closed Circuit Television footage before reaching their conclusions.
The investigation found that SEGAL failed to enforce the Standard Operating Procedure (SOP) on security and access control at the Central Medicine Store.
The SOP required security officers to provide an independent third-party check on all movement of stock entering and leaving the warehouse.
Security personnel were expected to serve as the first point of contact for vehicles arriving at the facility for deliveries or dispatches, record relevant information in vehicle logbooks, and monitor movements involving pharmaceutical commodities.
Investigators concluded that these procedures were not properly enforced. The NSA report cited missing pharmaceutical commodities valued at US$375,973.50 based on an audit conducted from April 1 to September 30, 2022.
The investigation also identified an additional US$112,455 worth of Artesunate injectable products reportedly received at the Central Medicine Store on September 13, 2022, but later reported missing.
Together, the figures cited by investigators amount to approximately US$488,428.50 worth of pharmaceutical commodities.
The findings have triggered questions about security controls, inventory management, documentation systems, and accountability mechanisms at a facility responsible for storing essential medicines.
Artesunate Shipment Raises Documentation Questions
The NSA investigation also focused on a shipment of Artesunate injectable products, a critical malaria treatment medication.
Investigators found that Assistant Warehouse Supervisor Baimba K. Adams received one 20-foot container and one 40-foot container reportedly containing 1,500 Artesunate injectable products on September 13, 2022.
The arrival of the containers was reportedly confirmed through video footage. However, the investigation stated that original documents related to the consignment were withheld, preventing the received commodities from being properly entered into the M-Supply inventory system.
The report also examined the roles of other CMS officials involved in receiving and processing pharmaceutical supplies.
Warehouse officials, reception personnel, security officers, and technical staff were all reviewed as investigators attempted to determine how medicines could enter the facility but later become unaccounted for.
CMS Officer Questions Investigation Process
Among those who provided statements was CMS’s Data Officer J. Ebenezer Yelorbah.
According to his statement, Yelorbah’s responsibilities included preparing picking slips and customer invoices, assisting with uploading information into the CMS website and M-Supply system, and supporting inventory processes.
Yelorbah told investigators that he was not involved in processing the Artesunate products into the system.
He also stated that he was never contacted by the Internal Audit team during its investigation.
According to his account, he only learned about the alleged missing medicines when department and unit heads were called to a meeting to hear the Internal Audit preliminary report.
“I don’t know whether my suspension came as a result of the IA Report of which I was not spoken to or neither invited by them for questioning,” Yelorbah stated. His comments have added another dimension to the debate over whether all individuals affected by disciplinary actions were given adequate opportunities to respond during the investigation.
Technical Failures and Missing Surveillance Footage
CMS IT Officer Joseph Guddah also provided information regarding challenges affecting the facility’s security technology. According to Guddah’s statement, the Central Medicine Store experienced several technical problems involving access control systems, camera operations, network conflicts, and surveillance equipment.
He said some cameras were not functioning properly and that there were issues involving magnetic door locks, continuous network loops, and IP conflicts.
Guddah told investigators that a service provider arrived at the CMS facility on September 14, 2022, to begin technical repairs. He explained that while technicians worked on configuring the Network Video Recorder system, he worked on IP and MAC binding for the facility’s cameras.
According to his statement, the technical work affected the availability of complete camera footage during that period. The revelations have raised further questions about whether weaknesses in surveillance systems contributed to accountability gaps at the warehouse.
Senator Cyrus Rejects Calls to Step Aside
While SEGAL faces public scrutiny over the CMS findings, Senator Cyrus has also faced criticism because of the company’s connection to discussions surrounding the US$19 million narcotics seizure at Roberts International Airport last month.
The senator’s office has rejected suggestions that SEGAL’s contractual relationship with GLS Mengies creates responsibility for the alleged drug trafficking incident.
The statement emphasized that SEGAL’s responsibilities at the airport are limited to perimeter security. It argued that the company does not inspect cargo, verify cargo documents, operate scanners, supervise customs procedures, conduct narcotics detection, or lead criminal investigations.
According to Senator Cyrus’ office, those responsibilities belong to government agencies responsible for customs, aviation security, law enforcement, and narcotics enforcement.
The senator has maintained that he has nothing to hide and that investigations should determine responsibility based on evidence rather than political pressure.
The Senate Committee Question
Despite Senator Cyrus’ explanation, his continued leadership as Chairman of the Senate Committee on National Defense, Intelligence, Security, and Veteran Affairs has become a central point of public debate.
The committee is one of the Senate’s most influential oversight bodies, with responsibility for examining matters involving national security institutions, intelligence agencies, defense structures, and security policies.
Critics argue that because SEGAL is a private security company connected to the senator’s history and has become part of national discussions involving security investigations, the senator’s continued leadership raises questions about perception and institutional confidence.
They argue that stepping aside would not represent an admission of guilt but could help protect the credibility of the committee and demonstrate a commitment to transparency.
Supporters of Senator Cyrus disagree, maintaining that removing an elected official from a constitutional responsibility based on allegations would violate principles of fairness and due process.
They argue that Senator Cyrus has already separated himself from SEGAL management and should not be punished because of his past association with a private company.
Code of Conduct Debate Takes Center Stage
At the heart of the controversy is Liberia’s Code of Conduct and the question of how public officials should handle situations where private interests and public responsibilities intersect.
The Code of Conduct establishes ethical standards requiring public officials to avoid conflicts between personal interests and official duties.
The debate surrounding Senator Cyrus is not only whether he currently manages SEGAL, but whether his continued association with the company creates an appearance of conflict while he occupies a position involving national security oversight.
Critics argue that public officials must consider not only legal compliance but also public perception, especially when they oversee institutions connected to matters affecting national security.
They maintain that leadership requires avoiding circumstances that could weaken public confidence in government institutions. Senator Cyrus and his supporters argue that ethical concerns must still be balanced with constitutional rights and the presumption of innocence.
Between Law, Ethics, and Public Trust
The controversy surrounding Senator Momo Cyrus represents a national debate about the relationship between private business interests and public office.
At one level, the senator argues that he complied with legal requirements by leaving SEGAL management when he entered government.
At another level, critics argue that public officials holding sensitive oversight positions must sometimes go beyond minimum legal requirements to protect public confidence.
The unresolved question is whether resignation from company management is enough when that company becomes connected to investigations involving public resources and national security concerns.
